Individual Submission Summary
Share...

Direct link:

Impact of State Prenatal Drug Use Reporting Laws on Drug Testing and Substance Use Disorder Diagnosis

Thursday, November 5, 8:30 to 10:00am, Property: Boston Marriott Copley Place, Floor: 3rd Floor, Room: Simmons

Abstract

Introduction/Background: States have enacted various laws in response to rising rates of prenatal drug use. Mandatory reporting laws require providers to report prenatal drug use to child welfare agencies; this may increase drug screening practices, heighten fear of custody loss, and discourage use of health care services. Priority access laws aim to facilitate rapid entry into publicly-funded substance use disorder (SUD) treatment, which may increase rates of SUD screening and diagnosis. 

Purpose/Research Question: This study evaluates the impact of state mandatory reporting and priority access laws on drug testing and SUD diagnosis among pregnant Medicaid enrollees. 

Data: We linked a state prenatal drug policy database to the national Transformed Medicaid Statistical Information System (T-MSIS) Analytic Files (TAF) data for 2015-2021. 

Methods: Separate sets of two-way fixed effects models were estimated for each policy, with standard errors clustered at the state level. For each policy, the treatment group included enrollees in states that enacted the relevant law in the study period and comparison enrollees were in states that never had the policy in place during the study period. States with the relevant policy in place during the full study period or with indicators of poor state-year Medicaid data quality were excluded. Key outcomes included binary measures of any urine drug test (UDT) and any SUD diagnosis during the prenatal period. 

Results: The samples included 7,486,932 prenatal periods in 33 states (for the mandatory reporting models) and 7,492,823 prenatal periods in 30 states (for the priority access models).  Enrollees were 27 years on average with 2% less than 18 years. Enactment of the reporting law was associated with 6.1 percentage point (ppt) (95% CI: 1.4, 10.8) greater probability of having a UDT and 1.0 ppt (95% CI: 0.5, 1.4) greater probability of having a SUD diagnosis. The priority access law was not associated with any change in the probability of having a UDT (0.5 ppt, 95% CI: -2.0, 3.0) or a SUD diagnosis (0.2 ppt, 95% CI: -0.4, 0.9). 

Implications: State prenatal drug policies may shape substance use surveillance and diagnosis in the health system during pregnancy. Mandatory reporting laws may heighten identification of pregnant Medicaid enrollees with substance use-related concerns. While this may increase opportunities for engagement in services, it may also increase risk of child welfare system involvement. Priority access laws were not associated with changes in identification of individuals in need of SUD treatment.

Author